Germany – Pharmaceutical products – Medicinal product discount agreements pursuant to Section 130a(8) SGB V within the framework of open-house procedures

Opportunity description

IKK classic hereby announces that, during the period from 01.09.2026 to 31.08.2028, it will conclude non-exclusive discount agreements pursuant to Section 130a(8) SGB V, under identical, non-negotiable conditions, with all interested and suitable pharmaceutical companies for various active substances and combinations of active substances. The earliest contract start date is 01.09.2026, provided that the signed contract and all necessary supporting evidence, self-declarations and documents are received by IKK classic by 07.08.2026. Thereafter, the following applies: If the documents are received by the 05th of a given month within the possible accession period, the contract will commence on the 01st of the following month. If the documents are received after the 05th of a given month within the possible accession period, the contract will commence on the 01st of the second following month. Accession to the agreement is possible at any time during the specified period, but no later than 05.07.2028. For further information, see point VI.3). Aclidinium bromide; ATC code: R03BB05 Anakinra; ATC code: L04AC03 Brivaracetam; ATC code: N03AX23 Quinine; ATC code: P01BC01 (WHO), M09AA02 (ADV) Darbepoetin; ATC code: B03XA02 Dexamfetamine; ATC code: N06BA02 Epoetin beta; ATC code: B03XA01 Epoetin theta; ATC code: B03XA01 Felodipine and Ramipril; ATC code: C09BB05 Golimumab; ATC code: L04AB06 Hydrocortisone; ATC code: H02AB09 Methylprednisolone aceponate; ATC code: D07AC14 Minoxidil; ATC code: C02DC01 Naloxegol; ATC code: A06AH03 Ocrelizumab; ATC code: L04AG08 Paliperidone; prolonged-release suspension for injection; strength from 175 mg; ATC code: N05AX13 PEG-Epoetin beta; ATC code: B03XA03 Perampanel; ATC code: N03AX22 Perindopril, Amlodipine and Indapamide; ATC code: C09BX01 Ranibizumab; vials; ATC code: S01LA04 Ranibizumab; pre-filled syringes; ATC code: S01LA04 Teduglutide; ATC code: A16AX08 Thalidomide; ATC code: L04AX02 Formoterol, Glycopyrronium bromide and Budesonide; ATC code: R03AL11 Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.